Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterizing the Clinical Trajectory and Predicting Persistence and Deterioration of Attenuated Psychotic Symptoms in Ultra-High-Risk Individuals.
Wannan C, Scott I, Dwyer D, Clark SR, Hartmann S, Ye RR, Amminger GP, Yuen HP, Lavoie S, Markulev C, Schaefer MR, Hartmann JA, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Kerr M, Spark J, Wallis N, Polari A, McGorry PD, Nelson B. Wannan C, et al. Among authors: schlogelhofer m. Schizophr Bull. 2024 Dec 20:sbae204. doi: 10.1093/schbul/sbae204. Online ahead of print. Schizophr Bull. 2024. PMID: 39707153
Emotion recognition in individuals at clinical high-risk for schizophrenia.
Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Schlögelhofer M, Mossaheb N, Werneck-Rohrer S, Nelson B, McGorry PD. Amminger GP, et al. Among authors: schlogelhofer m. Schizophr Bull. 2012 Sep;38(5):1030-9. doi: 10.1093/schbul/sbr015. Epub 2011 Mar 21. Schizophr Bull. 2012. PMID: 21422108 Free PMC article.
Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.
Smesny S, Milleit B, Schaefer MR, Hesse J, Schlögelhofer M, Langbein K, Hipler UC, Berger M, Cotter DR, Sauer H, McGorry PD, Amminger GP. Smesny S, et al. Among authors: schlogelhofer m. Schizophr Res. 2017 Oct;188:110-117. doi: 10.1016/j.schres.2017.01.026. Epub 2017 Jan 23. Schizophr Res. 2017. PMID: 28126360 Clinical Trial.
NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course.
Nelson B, Amminger GP, Yuen HP, Markulev C, Lavoie S, Schäfer MR, Hartmann JA, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD. Nelson B, et al. Among authors: schlogelhofer m. NPJ Schizophr. 2018 Jun 25;4(1):11. doi: 10.1038/s41537-018-0052-x. NPJ Schizophr. 2018. PMID: 29941938 Free PMC article.
Dynamic prediction of transition to psychosis using joint modelling.
Yuen HP, Mackinnon A, Hartmann J, Amminger GP, Markulev C, Lavoie S, Schäfer MR, Polari A, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD, Nelson B. Yuen HP, et al. Among authors: schlogelhofer m. Schizophr Res. 2018 Dec;202:333-340. doi: 10.1016/j.schres.2018.07.002. Epub 2018 Jul 7. Schizophr Res. 2018. PMID: 30539771 Clinical Trial.
Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
Bolt LK, Amminger GP, Farhall J, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Allott KA. Bolt LK, et al. Among authors: schlogelhofer m. Schizophr Res. 2019 Apr;206:67-74. doi: 10.1016/j.schres.2018.12.013. Epub 2018 Dec 14. Schizophr Res. 2019. PMID: 30558978
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people.
Alqarni A, Mitchell TW, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Amminger GP, Meyer BJ. Alqarni A, et al. Among authors: schlogelhofer m. Schizophr Res. 2020 Dec;226:44-51. doi: 10.1016/j.schres.2019.06.020. Epub 2019 Jul 10. Schizophr Res. 2020. PMID: 31301881
Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis.
Alqarni A, Mitchell TW, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Meyer BJ, Amminger GP. Alqarni A, et al. Among authors: schlogelhofer m. Schizophr Res. 2020 Dec;226:52-60. doi: 10.1016/j.schres.2019.08.033. Epub 2019 Oct 9. Schizophr Res. 2020. PMID: 31606244 Clinical Trial.
Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes.
Youn S, Phillips LJ, Amminger GP, Berger G, Chen EYH, de Haan L, Hartmann JA, Hickie IB, Lavoie S, Markulev C, McGorry PD, Mossaheb N, Nieman DH, Nordentoft M, Riecher-Rössler A, Schäfer MR, Schlögelhofer M, Smesny S, Thompson A, Verma S, Yuen HP, Yung AR, Nelson B. Youn S, et al. Among authors: schlogelhofer m. Schizophr Res. 2020 Feb;216:255-261. doi: 10.1016/j.schres.2019.11.047. Epub 2019 Dec 19. Schizophr Res. 2020. PMID: 31866077
55 results